<DOC>
	<DOC>NCT01699529</DOC>
	<brief_summary>This is a prospective, single-arm, non-randomized and open label feasibility study. The study is intended to evaluate safety and efficacy of multi-electrode radiofrequency renal denervation in patients with uncontrolled hypertension.</brief_summary>
	<brief_title>Multi-electrode Radiofrequency Renal Denervation System Feasibility Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Individual is ≥ 18 and ≤ 80 years old. Individual has an office systolic blood pressure of 160 mmHG or greater (≥ 150 mmHg for Type 2 diabetics) based on an average of 3 office/clinic blood pressure readings Individual is adhering to a stable medication regimen including ≥ 3 antihypertensive medications(preferred that one is a diuretic) for a minimum of two weeks prior to screening. Individual has an estimated glomerular filtration rate (eGFR) of &lt; 45 mL/min/1.73 m2 Individual has type 1 diabetes mellitus Individual requires chronic oxygen support or mechanical ventilation (e.g., tracheostomy, CPAP, BiPAP) other than nocturnal respiratory support for sleep apnea. Individual has primary pulmonary hypertension. Individual is pregnant, nursing or planning to be pregnant.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>